SLC25A32 expression is positively correlated with the malignant biological functions of most tumours, including metastasis, differentiation, inflammation, angiogenesis, apoptosis, cell proliferation, stemness, and epithelial–mesenchymal transition (EMT). The gene discussed is SLC25A32; the disease is neoplasm.